Search companies or stocks...
XENEXenon Pharmaceuticals Inc.
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its…
Current stock price of Xenon Pharmaceuticals Inc. (XENE) stock is $36.410. The stock price is -0.44% lower in the session. The intraday range can be seen from this page. Volume of Xenon Pharmaceuticals Inc. (XENE) stock is 1.97M.
Last updated at 07 Oct 2026, 08:00 pm.
The stock price of Xenon Pharmaceuticals Inc. (XENE) can change with earnings, company news, and overall market sentiment. Xenon Pharmaceuticals Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Xenon Pharmaceuticals Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for XENE on this page is -7.75. EPS on this page is -4.70. Compare those figures with peers and growth expectations before deciding if the current Xenon Pharmaceuticals Inc. price is justified.
Historical performance for Xenon Pharmaceuticals Inc. (XENE) is shown on the price chart on this page. Review multi-period moves alongside volume to see how XENE reacted to past earnings and market events.
Buying Xenon Pharmaceuticals Inc. (XENE) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
